Sleep and circadian rhythm of melatonin in Smith-Magenis syndrome

Neuroendocrine Correlates of Sleep/Wakefulness

Volumn , Issue , 2006, Pages 259-267

  De Leersnyder, Hélène ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747865673     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-23692-9_13     Document Type: Chapter

References (25)

1. Smith, A. C. M.; McGavran, L.; Robinson, J.; Waldstein, G.; Macfarlane, J.; Zonana, I; Reiss, J.; Lahr, M.; Allen, L.; Magenis, E.: Interstitial deletion of (17) (pll. 2pll. 2) in nine patients. Am. J. Med. Genet. 24:393-414, (1986).
2. Greenberg, R; Guzzetta, V; Montes de Oca-Luna, R.; Magenis, R. E.; Smith, A. C. M.; Richter, S. E; Kondo, I.; Dobyns, W B.; Patel, P. L; Lupski, J. R.: Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del (17) (pl 1. 2). Am. J. Hum. Genet. 49:1207-1218, (1991).
3. Moncla, A.; Piras, L.; Arbex, O. E; Muscatelli, E; Mattei, M.-G.; Mattei, J.-E; Fontes, M.: Physical mapping of microdeletions of the chromosome 17 short arm associated with Smith-Magenis syndrome. Hum. Genet. 90:657-660, (1993).
4. Juyal R. C., Figuera L. E., Hauge X., Elsea S. H., Lupski J. R., Greenberg E, Baldini A., Patel P. I., Molecular analysis of 17pll. 2 deletion in 62 Smith-Magenin syndrome patients., 4m. J. Hum. Genet. 58:998-1007. (1996)
5. Greenberg F, Lewis RA, Potocki L, Glaze L, Parke J, Killian J, et al. Multi disciplinary clinical study of Smith-Magenis syndrome (deletion 17pl 1. 2). Am J Med Genet 62:247-54. (1996)
6. Smith ACM, Dykens E, Greenberg E Behavioral phenotype of Smith-Magenis syndrome (del 17pl 1. 2) Am J Med Genet; 81:179-185 (1998)
7. Boddaert N., De Leersnyder H., Bourgeois M., Munnich A., Brunelle E, Zilbovivius M. Anatomical and functional brain imaging evidence of lenticulo-insular anomalies in Smith Magenis syndrome. Neuroimage 21 1021-1025. (2004)
8. Smith ACM, Dykens E, Greenberg E Sleep disturbance in Smith-Magenis syndrome (del 17pll. 2). Am J Med Genet;S 1:186-91. (1998)
9. Lucas, R. E.; Vlangos, C. N.; Das, P.; Patel, P. L; Elsea, S. H.: Genomic organisation of the -1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis. Europ. J. Hum. Genet. 9:892-902 (2001).
10. Potocki, L.; Chen, K.-S.; Park, S.-S.; Osterholm, D. E.; Withers, M. A.; Kimonis, V; Summers, A. M.; Meschino, W. S.; Anyane-Yeboa, K.; Kashork, C. D.; Shaffer, L. G.; Lupski, J. R.: Molecular mechanism for duplication 17pl 1.2-the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nature Genet. 24:84-87 (2000).
11. Slager, R. E.; Newton, T. L.; Vlangos, C. N.; Finucane, B.; Elsea, S. H.: Mutations in RAH associated with Smith-Magenis syndrome. Nature Genet. 33:466-468, (2003).
12. Potocki, L.; Glaze, D.; Tan, D.-X.; Park, S.-S.; Kashork, C. D.; Shaffer, L. G.; Reiter, R. J.; Lupski, J. R.: Orcadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. J. Med. Genet. 37:428-433, (2000).
13. De Leersnyder, H.; de Blois, M.-C.; Claustrat, B.; Romana, S.; Albrecht, U.; von Kleist-Retzow, J.-C.; Delobel, B.; Viot, Q; Lyonnet, S.; Vekemans, M.; Munnich, A.: Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J. Pediat. 139:111-116, (2001).
14. Cavallo A. Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages. Neuroendocrinology; 55:372-9. (1992)
15. Cornelissen G., Halberg E, Tarquini R., Perfetto E, Salti R., Laffi G, Otsuka K. Point and interval estimations of circadian melatonin ecphasia in Smith-Magenis syndrome. BiomedPharmacother. 57.1:39-44. (2003)
16. Moore RY. Circadian rhythms: basic neurobiology and clinical applications. Annu. Rev. Med.; 48:253-266. (1997)
17. Brzezinski A. Melatonin in humans. N EnglJ Med; 336:186-95. (1997)
18. Van Esseveldt L. E. Lehman M. N. Boer G. J. The suprachiasmatic nucleus and the circadian time-keeping system revisited. Brain Research Reviews 33:34-77. (2000)
19. Wager-Smith K. Kay S. A. Circadian rhythms genetics: from flies to mice to humans. Nature genetics. 26:23-27. (2000)
20. Potocki L, Chen KS, Lupski J. Subunit 3 of the COP9 signal transduction complex is conserved from plants to humans and maps within the Smith-Magenis syndrome critical region in 17pll.2. Genomics; 57:180-2. (1999)
21. Arendt J. Mamalian pineal rhythms. Pineal Res Rev. 3:161-213. (1985)
22. Jan J. E., Freeman R. D., Fast D. K. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Dev. Med. Child. Neurol. 41, 491-500. (1999)
23. De Leersnyder, H.; de Blois, M.-C.; Vekemans, M.; Sidi, D.; Villain, E.; Kindermans, C; Munnich, A.: Beta-1-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. J. Med Genet. 38:586-590, (2001).
24. De Leersnyder, H.; Bresson J. L. de Blois, M.-C.; Souberbielle J. C., Mogenet A., Delhotal-Landes B., Salefranque F, Munnich, A.: Beta-1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J. Med. Genet. 40:74-78, (2003).
25. Stoschitzky K., Sakotnik A., Lercher P., Sweiker R., Maier R., Liebmann P., Lindner W Infdluence of beta blockers on melatonin release. Eur. J. Clin. Pharmacol. 55:111-1. (1999).